about
Determinants of respiratory pump function in patients with cystic fibrosis.Ventilation/perfusion ratio and right to left shunt in healthy newborn infants.Using Measurements of Shunt and Ventilation-to-Perfusion Ratio to Quantify the Severity of Bronchopulmonary Dysplasia.Health-promoting properties of bioactive peptides derived from milk proteins in infant food: a review.Respiratory function parameters in ventilated newborn infants undergoing whole body hypothermia.Sustained inflations versus UK standard inflations during initial resuscitation of prematurely born infants in the delivery room: a study protocol for a randomised controlled trial.Physiological and anatomical dead space in mechanically ventilated newborn infants.Volume targeting levels and work of breathing in infants with evolving or established bronchopulmonary dysplasia.Effect of maturity and infection on the rate of relaxation of the respiratory muscles in ventilated, newborn infants.On the Relation of Pseudomonas aeruginosa Infection and Respiratory Muscle Function in Adolescents and Adults with Cystic Fibrosis.Relaxation Rate of the Respiratory Muscles and Prediction of Extubation Outcome in Prematurely Born Infants.Deltoid muscle morphometry as an index of impaired skeletal muscularity in neonatal intensive care.Determinants of pulmonary dead space in ventilated newborn infants.Admissions for hypoglycaemia after 35 weeks of gestation: perinatal predictors of cost of stay.Correlation of radiographic thoracic area and oxygenation impairment in bronchopulmonary dysplasia.Time constant of inspiratory muscle relaxation in cystic fibrosis.High-flow nasal cannula on transport: moving with the times.Ventilation Efficiency and Respiratory Muscle Function at Different Levels of CPAP in Intubated Prematurely Born InfantsNutritional status and pulmonary outcome in children and young people with cystic fibrosisPrediction of bronchopulmonary dysplasia developmentPredictors of outcome of prematurely born infants with pulmonary interstitial emphysemaFactors contributing to the failure of humidified high-flow nasal cannulaeAdverse neonatal outcomes and house prices in LondonKey paediatric messages from the 2018 European Respiratory Society International CongressMaximum rate of pressure development and maximal relaxation rate of respiratory muscles in patients with cystic fibrosisCorrigendum to "Determinants of pulmonary dead space in ventilated newborn infants" [Early Hum. Dev. 108 (2017) 29-32]Introducing high-flow nasal cannula to the neonatal transport environmentUsing the fetal oxyhaemoglobin dissociation curve to calculate the ventilation/perfusion ratio and right to left shunt in healthy newborn infantsChronology and Determinants of Respiratory Function Changes Following Administration of Systemic Postnatal Corticosteroids in Extremely Preterm InfantsAssessment of sidestream end-tidal capnography in ventilated infants on the neonatal unitElectrical activity of the diaphragm following a loading dose of caffeine citrate in ventilated preterm infantsSustained inflations during delivery suite stabilisation in prematurely-born infants - A randomised trialProlonged ventilation and postnatal growth of preterm infantsClosed loop automated oxygen control in neonates-A reviewUK survey of less invasive surfactant administrationTransient neonatal hyperinsulinaemic hypoglycaemia: perinatal predictors of length and cost of stayPrediction of prolonged ventilator dependence in preterm infantsVolumetric capnography slopes in ventilated term and preterm infantsOutcomes of infants with congenital diaphragmatic hernia by side of defect in the FETO eraDiaphragm electromyography results at different high flow nasal cannula flow rates
P50
Q38198815-3BE0ED90-277B-46FA-ACD1-B6D196544281Q39067327-276040F8-E007-4408-ACB3-BAA6C83D2F21Q41233637-F79E6812-915B-413D-B732-1A75308B1016Q42649952-CFE71FB5-0C16-49A1-A0A4-93FFD1119105Q44889561-4EBF1C3C-93D8-402B-83D7-6D378F4E2AC3Q47097989-18731135-E465-4F7B-855D-15EB3446AB94Q47448101-B1F5702B-A402-49F2-BF1C-D1CE0E311CDCQ47664521-B3850F28-F35F-44CD-9783-4E5D3A3BC94EQ47680147-1F23360A-F810-4584-93CE-26BCE37A0F8BQ47761588-775CE855-2C28-43A7-8019-A4E5086D378BQ47834655-FE7A7222-E15F-4D28-B936-01EC997824A0Q47852164-D86EBA56-67AC-4CF4-A208-150541D979D9Q47903949-5F46BD68-8E3C-488E-911F-3F5E45682702Q48328387-4EC4F822-EE10-4D22-9581-1BC04CDE1AFBQ51590963-5E53104B-2EEE-425F-B52C-07D12E56F015Q51662396-8A84AEEB-917F-44A7-BF47-8726EDEE74BFQ53555326-567D92FD-687A-43DB-8C09-95EAA92AA7D1Q58608697-5D8B565B-1081-4CB1-BF65-FA8ADE2B8865Q59629237-8931508E-252D-4E31-ADCB-44153BF34C6CQ59629261-E8E0A4C0-ABE5-40F0-B598-DECD71268168Q59629274-4FF39F15-2452-4BB3-853D-5DCBA89D100FQ59629310-42BD11A0-8255-4487-9F2F-8A1323ECDCEBQ59629462-A1EF3FFC-719B-412E-9395-0059B4B3F0D4Q64081136-91D92C93-A335-4E8C-9EED-33838D973BC0Q84559808-62EBA681-9D56-48E3-95A2-AD37E3508CEFQ88287765-30957EAC-2E43-47E3-B412-D8C5CF747D23Q88986129-784F6696-D884-4858-9DB9-557F143AE526Q89017533-5A2785F3-2428-4644-B67E-6D35FB3536C3Q89999588-61F35FF6-EF48-45D9-8BED-D6856387E7BBQ90432208-8AE2A5B4-6A47-4275-B86B-63F9B94B8051Q90773600-7D614104-B53A-40EF-9FDB-B2AAEEE2BEE0Q91038429-BA9BAED9-35B3-48A4-A88F-E4721E5B1183Q91244514-4132A127-2F4B-4BEC-B9CB-186D00BC858DQ91245205-87C4C0EA-CE94-487C-9A4C-6DF80DCF330BQ91467127-7252E94F-0C75-4DB8-8533-8A7A62F7BCF4Q91557222-50B82A72-EEE4-427B-BB1A-4FE352F62FA1Q91933245-444BF69E-20F0-4716-87A5-873E9371F649Q91991834-44AC316D-010C-42D2-92A9-D6CB2F84A9F7Q92027679-E43B31DF-CD6A-42BD-B425-792AB07F5F2DQ92673626-8EE8F098-6F24-4114-B819-C822314E5260
P50
description
researcher ORCID ID = 0000-0001-5258-5301
@en
name
Theodore Dassios
@ast
Theodore Dassios
@en
Theodore Dassios
@es
Theodore Dassios
@nl
type
label
Theodore Dassios
@ast
Theodore Dassios
@en
Theodore Dassios
@es
Theodore Dassios
@nl
prefLabel
Theodore Dassios
@ast
Theodore Dassios
@en
Theodore Dassios
@es
Theodore Dassios
@nl
P31
P496
0000-0001-5258-5301